(Q24530904)

3 July 2017

title

15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL (English)

1 reference

3 July 2017

1

Maurizio Fava

Maurizio

Fava

1 reference

3 July 2017

4

Anita Clayton

Anita

Clayton

1 reference

3 July 2017

5

Stephen M Stahl

Stephen M

Stahl

1 reference

3 July 2017

2

A John Rush

A John

Rush

1 reference

3 July 2017

3

Michael E Thase

Michael E

Thase

1 reference

3 July 2017

James F Pradko

6

James F

Pradko

1 reference

3 July 2017

J Andrew Johnston

series ordinal

7

author given names

J Andrew

author last names

Johnston

1 reference

3 July 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Primary Care Companion to the Journal of Clinical Psychiatry

3 July 2017

published in

1 reference

3 July 2017

volume

7

1 reference

3 July 2017

issue

3

1 reference

3 July 2017

page(s)

106-113

1 reference

A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor

3 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Dopamine transporter-dependent induction of C-Fos in HEK cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Prevalence of sexual dysfunction among newer antidepressants.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Sexual functioning and SSRIs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Use of bupropion with SRIs and venlafaxine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion sustained release: side effect profile.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Synaptic effects of antidepressants

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion: a review of its mechanism of antidepressant activity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Studies of bupropion's mechanism of antidepressant activity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Safety profile of sustained-release bupropion in depression: results of three clinical trials

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A double-blind trial of bupropion versus desipramine for bipolar depression

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

The efficacy of bupropion in winter depression: results of an open trial

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Switching to bupropion in fluoxetine-resistant major depressive disorder

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Comparison of bupropion and trazodone for the treatment of major depression

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

The pharmacologic basis for therapeutic interest in bupropion.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Efficacy of bupropion in tricyclic-resistant or intolerant patients.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Clinical pharmacology of bupropion and imipramine in elderly depressives.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1163271

Double-blind comparison of bupropion and fluoxetine in depressed outpatients

29 November 2018

1 reference

12 December 2020

A comparative study of bupropion and amitriptyline in depressed outpatients

1 reference

12 December 2020

Bupropion's prophylactic efficacy in bipolar affective illness

1 reference

12 December 2020

Bupropion treatment of attention-deficit hyperactivity disorder in adults

1 reference

12 December 2020

Bupropion in Tricyclic Antidepressant Nonresponders with Unipolar Major Depressive Disorder

1 reference

12 December 2020

Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Identifiers

DOI

10.4088/PCC.V07N0305

1 reference

release_xxiysvykdrgmnlkqzdfylsuztu

3 July 2017

Fatcat ID

0 references

OpenCitations bibliographic resource ID

3069143

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3069143

1 reference